Pacific Biosciences of California (PACB)

Pacific Biosciences of California, Inc. is a healthcare company listed on NASDAQ as common stock under the ticker PACB. It designs, develops, and manufactures sequencing solutions used to address genetically complex problems. The company’s product portfolio includes sequencing systems, consumable products built around single molecule real-time (SMRT) technology, long-read sequencing solutions, and reagent kits for specific laboratory workflows. Its offerings also include preparation kits, binding kits, and sequencing kits that support the sequencing process, along with instruments such as Revio, Vega, Sequel, and onso. These systems are used to conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips. Pacific Biosciences serves academic, government, clinical, commercial, and research customers across multiple regions through direct sales and distribution partners. The company was incorporated in 2000, became Pacific Biosciences of California in 2005, and is headquartered in Menlo Park, California.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.